Detecting 72 genes most commonly mutated in lung cancer

Detecting 72 genes most commonly mutated in lung cancer

Anatomy - Pathology / Cytogenetics / Molecular Diagnostics

December 14, 2016

Interested in the simultaneous detection of 72 genes most commonly mutated in lung cancer with high confidence? The newly developed Human Lung Cancer QIAseq DNA Panel provides you with a complete Sample to Insight solution and a simple, streamlined workflow.

The panel combines single primer extension (SPE) technology and unique molecular indices (UMIs) to enable sequencing of GC-rich regions, direct quantitation of CNVs, accurate expression level measurement and variant call validation. The simplicity of the system makes it ideal for routine known and novel lung cancer mutation detection on any NGS platform from Illumina and Ion Torrent.

SOMATIC 2 MASTR Plus and QC Plex Product Release

SOMATIC 2 MASTR Plus and QC Plex Product Release

Anatomy - Pathology / Cytogenetics / Molecular Dia...

Multiplicom is pleased to introduce the SOMATIC 2 MASTR™ Plus, a research use only assay, for sequencing analysis of genes involved in pathways of solid tumors formation. The SOMATIC 2 MASTR Plus is provided as a ready to use assay in three multiplex PCR reactions for the identification of mutations in the complete coding regions of the EGFR, ERBB2, PIK3CA, PIK3R1 and PTEN genes.

March 24, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us